CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants

Detalhes bibliográficos
Autor(a) principal: Silva, Roseli da
Data de Publicação: 2013
Outros Autores: Marie, Suely K. N., Uno, Miyuki, Matushita, Hamilton, Wakamatsu, Alda, Rosemberg, Sergio, Oba-Shinjo, Sueli M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/53154
Resumo: OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas.
id USP-19_b557de591ae121b375c1a05f182b66f5
oai_identifier_str oai:revistas.usp.br:article/53154
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants Gene ExpressionImmunohistochemistryMedulloblastomaWnt Pathway OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/5315410.6061/CLINICS/2013(02)OA08Clinics; Vol. 68 No. 2 (2013); 167-172 Clinics; v. 68 n. 2 (2013); 167-172 Clinics; Vol. 68 Núm. 2 (2013); 167-172 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/53154/57215Silva, Roseli daMarie, Suely K. N.Uno, MiyukiMatushita, HamiltonWakamatsu, AldaRosemberg, SergioOba-Shinjo, Sueli M.info:eu-repo/semantics/openAccess2013-04-08T20:40:36Zoai:revistas.usp.br:article/53154Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2013-04-08T20:40:36Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
title CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
spellingShingle CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
Silva, Roseli da
Gene Expression
Immunohistochemistry
Medulloblastoma
Wnt Pathway
title_short CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
title_full CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
title_fullStr CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
title_full_unstemmed CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
title_sort CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
author Silva, Roseli da
author_facet Silva, Roseli da
Marie, Suely K. N.
Uno, Miyuki
Matushita, Hamilton
Wakamatsu, Alda
Rosemberg, Sergio
Oba-Shinjo, Sueli M.
author_role author
author2 Marie, Suely K. N.
Uno, Miyuki
Matushita, Hamilton
Wakamatsu, Alda
Rosemberg, Sergio
Oba-Shinjo, Sueli M.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva, Roseli da
Marie, Suely K. N.
Uno, Miyuki
Matushita, Hamilton
Wakamatsu, Alda
Rosemberg, Sergio
Oba-Shinjo, Sueli M.
dc.subject.por.fl_str_mv Gene Expression
Immunohistochemistry
Medulloblastoma
Wnt Pathway
topic Gene Expression
Immunohistochemistry
Medulloblastoma
Wnt Pathway
description OBJECTIVES: We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor. METHODS: Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information. RESULTS: CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants. CONCLUSIONS: A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/53154
10.6061/CLINICS/2013(02)OA08
url https://www.revistas.usp.br/clinics/article/view/53154
identifier_str_mv 10.6061/CLINICS/2013(02)OA08
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/53154/57215
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 68 No. 2 (2013); 167-172
Clinics; v. 68 n. 2 (2013); 167-172
Clinics; Vol. 68 Núm. 2 (2013); 167-172
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222759723204608